Literature DB >> 35580286

Reply to R.A. Snyder et al.

Nicholas D Klemen1, Paul L Feingold1, Barry Hashimoto1.   

Abstract

Entities:  

Year:  2022        PMID： 35580286      PMCID： PMC9467674          DOI： 10.1200/JCO.22.00320

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   50.717


× No keyword cloud information.
  16 in total

1.  Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study.

Authors:  Noémie Kraaijpoel; Suzanne M Bleker; Guy Meyer; Isabelle Mahé; Andrés Muñoz; Laurent Bertoletti; Annemarieke Bartels-Rutten; Jan Beyer-Westendorf; Ettore Porreca; Carine Boulon; Nick van Es; Diana I Iosub; Francis Couturaud; Mercedes Biosca; Teresa Lerede; Philippe Lacroix; Anthony Maraveyas; Anita Aggarwal; Philippe Girard; Harry R Büller; Marcello Di Nisio
Journal:  J Clin Oncol       Date:  2019-05-22       Impact factor: 44.544

2.  Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.

Authors:  Corinne Frere; Barbara Bournet; Sophie Gourgou; Julien Fraisse; Cindy Canivet; Jean M Connors; Louis Buscail; Dominique Farge
Journal:  Gastroenterology       Date:  2019-12-14       Impact factor: 22.682

3.  Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.

Authors:  Paul L den Exter; José Hooijer; Olaf M Dekkers; Menno V Huisman
Journal:  J Clin Oncol       Date:  2011-05-09       Impact factor: 44.544

Review 4.  Definitions, adjudication, and reporting of pulmonary embolism-related death in clinical studies: A systematic review.

Authors:  Noémie Kraaijpoel; Tobias Tritschler; Enora Guillo; Philippe Girard; Grégoire Le Gal
Journal:  J Thromb Haemost       Date:  2019-07-31       Impact factor: 5.824

5.  Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.

Authors:  Grégoire Le Gal; Michael J Kovacs; Laurent Bertoletti; Francis Couturaud; Carole Dennie; Andrew M Hirsch; Menno V Huisman; Frederikus A Klok; Noémie Kraaijpoel; Ranjeeta Mallick; Amanda Pecarskie; Elena Pena; Penny Phillips; Isabelle Pichon; Tim Ramsay; Marc Righini; Marc A Rodger; Pierre-Marie Roy; Olivier Sanchez; Jeannot Schmidt; Sam Schulman; Sudeep Shivakumar; Albert Trinh-Duc; Rachel Verdet; Ulric Vinsonneau; Philip Wells; Cynthia Wu; Erik Yeo; Marc Carrier
Journal:  Ann Intern Med       Date:  2021-11-23       Impact factor: 25.391

6.  Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis.

Authors:  Nicholas D Klemen; Paul L Feingold; Barry Hashimoto; Melinda Wang; Svetlana Kleyman; Alexandria Brackett; Cary P Gross; Kevin Y Pei
Journal:  Lancet Haematol       Date:  2020-08       Impact factor: 18.959

7.  Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update.

Authors:  Nigel S Key; Alok A Khorana; Nicole M Kuderer; Kari Bohlke; Agnes Y Y Lee; Juan I Arcelus; Sandra L Wong; Edward P Balaban; Christopher R Flowers; Charles W Francis; Leigh E Gates; Ajay K Kakkar; Mark N Levine; Howard A Liebman; Margaret A Tempero; Gary H Lyman; Anna Falanga
Journal:  J Clin Oncol       Date:  2019-08-05       Impact factor: 44.544

8.  Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study.

Authors:  Giancarlo Agnelli; Gualberto Gussoni; Carlo Bianchini; Melina Verso; Mario Mandalà; Luigi Cavanna; Sandro Barni; Roberto Labianca; Franco Buzzi; Giovanni Scambia; Rodolfo Passalacqua; Sergio Ricci; Giampietro Gasparini; Vito Lorusso; Erminio Bonizzoni; Maurizio Tonato
Journal:  Lancet Oncol       Date:  2009-08-31       Impact factor: 41.316

9.  How Strong Is the Evidence Supporting Thromboprophylaxis in Surgical Oncology?

Authors:  Nicholas D Klemen; Paul L Feingold; Barry Hashimoto
Journal:  J Clin Oncol       Date:  2021-12-06       Impact factor: 50.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.